Bonnefoy Luc 4

What Happened Luc Bonnefoy, President, Surgical at Bausch & Lomb Corporation (BLCO), was granted 30,373 restricted share units (RSUs) on 2026-02-25. The grant is reported as an acquisition at $0.00 (standard for equity awards); no cash changed hands at grant. This is a compensation award rather than a market purchase or sale.

Key Details

• Transaction date: 2026-02-25
• Transaction type: Award/Grant of RSUs (code A)
• Shares granted: 30,373 RSUs; price reported: $0.00 (grant value not reported in dollar terms on the Form 4)
• Shares owned after transaction: Not specified in the filing
• Footnote: F1 — RSUs are granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan and generally vest one‑third on each of the first three anniversaries of the grant date, subject to continued service; vested RSUs are settled in common shares.
• Filing timeliness: Reported on Form 4 filed 2026-02-27 for a 2026-02-25 grant — filed within the normal two-business-day window.

Context RSU grants are routine executive compensation and vest over time; they are not an immediate market purchase or sale. Because these RSUs vest in thirds over three years and are settled in common shares upon vesting, they represent future share issuance tied to continued service rather than an outright investment decision by the insider.